全文获取类型
收费全文 | 202827篇 |
免费 | 17209篇 |
国内免费 | 5911篇 |
专业分类
耳鼻咽喉 | 1853篇 |
儿科学 | 3303篇 |
妇产科学 | 1604篇 |
基础医学 | 25276篇 |
口腔科学 | 5126篇 |
临床医学 | 23529篇 |
内科学 | 25036篇 |
皮肤病学 | 1667篇 |
神经病学 | 10010篇 |
特种医学 | 20561篇 |
外国民族医学 | 49篇 |
外科学 | 17226篇 |
综合类 | 29978篇 |
现状与发展 | 15篇 |
一般理论 | 25篇 |
预防医学 | 11257篇 |
眼科学 | 7101篇 |
药学 | 17484篇 |
22篇 | |
中国医学 | 7995篇 |
肿瘤学 | 16830篇 |
出版年
2024年 | 183篇 |
2023年 | 2711篇 |
2022年 | 4036篇 |
2021年 | 7174篇 |
2020年 | 6617篇 |
2019年 | 6582篇 |
2018年 | 6548篇 |
2017年 | 6446篇 |
2016年 | 6692篇 |
2015年 | 6752篇 |
2014年 | 11274篇 |
2013年 | 11543篇 |
2012年 | 10458篇 |
2011年 | 11810篇 |
2010年 | 10314篇 |
2009年 | 10306篇 |
2008年 | 10303篇 |
2007年 | 11398篇 |
2006年 | 10406篇 |
2005年 | 10023篇 |
2004年 | 8628篇 |
2003年 | 7562篇 |
2002年 | 5691篇 |
2001年 | 5538篇 |
2000年 | 4486篇 |
1999年 | 4062篇 |
1998年 | 2811篇 |
1997年 | 2596篇 |
1996年 | 2576篇 |
1995年 | 2562篇 |
1994年 | 2258篇 |
1993年 | 1982篇 |
1992年 | 1677篇 |
1991年 | 1454篇 |
1990年 | 1238篇 |
1989年 | 1176篇 |
1988年 | 1093篇 |
1987年 | 889篇 |
1986年 | 658篇 |
1985年 | 762篇 |
1984年 | 796篇 |
1983年 | 490篇 |
1982年 | 631篇 |
1981年 | 530篇 |
1980年 | 439篇 |
1979年 | 362篇 |
1978年 | 281篇 |
1977年 | 240篇 |
1976年 | 260篇 |
1975年 | 150篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
3.
4.
5.
《Journal of vascular and interventional radiology : JVIR》2022,33(12):1531-1535
This study investigated the role of dual-energy computed tomography (CT) for lesion characterization in patients with peripheral arterial disease manifesting with chronic total occlusions (CTOs). Forty-one symptomatic patients with CTOs underwent dual-energy CT angiography before endovascular treatment. The lesions were subsequently analyzed in a dedicated workstation, and 2 indexes—dual-energy index (DEI) and effective Z (Zeff)—were calculated, ranging from 0.0027 to 0.321 and from 6.89 to 13.02, respectively. Statistical analysis showed a significant correlation between the DEI and Zeff values (P < .001). The interobserver intraclass correlation coefficient was 0.91 for the mean Zeff values and 0.86 for the mean DEI values. This technique could potentially provide useful information regarding the composition of a CTO. 相似文献
6.
《Radiography》2022,28(2):353-359
Patient contact shielding has been in use for many years in radiology departments in order to reduce the effects and risks of ionising radiation on certain organs. New technologies in projection imaging and CT scanning such as digital receptors and automatic exposure control (AEC) systems have reduced doses and improved image consistency. These changes and a greater understanding of both the benefits and the risks from the use of shielding have led to a review of shielding use in radiology. A number of professional bodies have already issued guidance in this regard. This paper represents the current consensus view of the main bodies involved in radiation safety and imaging in Europe: European Federation of Organisations for Medical Physics, European Federation of Radiographer Societies, European Society of Radiology, European Society of Paediatric Radiology, EuroSafe Imaging, European Radiation Dosimetry Group (EURADOS), and European Academy of DentoMaxilloFacial Radiology (EADMFR). It is based on the expert recommendations of the Gonad and Patient Shielding (GAPS) Group formed with the purpose of developing consensus in this area. The recommendations are intended to be clear and easy to use. They are intended as guidance, and they are developed using a multidisciplinary team approach. It is recognised that regulations, custom and practice vary widely on the use of patient shielding in Europe and it is hoped that these recommendations will inform a change management program that will benefit patients and staff. 相似文献
7.
地鳖中的纤溶活性蛋白是从地鳖中提取的具有抗栓及抗肿瘤作用的有效成分,其口服易被上消化道酶分解从而限制了应用。采用恒流泵滴制法开发地鳖纤溶活性蛋白时间/pH依赖口服结肠靶向微囊(EnpolypHaga fibrinolytic protein oral colon targeting microcapsules, CTM-EFP)。采用单因素实验和正交实验相结合的方法寻找到包封率为60.17 % ± 2.72 %、载药量为15.50 % ± 0.44 % 的最佳配方。扫描电子显微镜(SEM)显示微囊呈球形、表面光滑,在人工肠液中24 h的累积释放度为99.53 % ± 0.69 %,在人工胃液中24 h累积释放度为7.43 ± 1.04 %,通过时间/pH依赖达到结肠靶向作用。CTM-EFP在人工肠液中的体外释放曲线符合Korsmeyer方程,提示地鳖纤溶活性蛋白(EnpolypHaga fibrinolytic protein, EFP)是通过扩散和侵蚀机制结合释放的。CTM-EFP为EFP的口服给药提供了一种新的剂型,为EFP应用于临床提供参考。 相似文献
8.
阿尔茨海默病是一种进行性且不可逆转的神经系统疾病,由于视网膜和中枢神经系统有相似的胚胎起源和生理特征,眼科检查可提供简单无创的诊断方法。光学相干断层扫描技术(OCT)能够精确地测量视网膜各个组织层面的厚度,以评估视网膜的退行性改变,光学相干断层扫描血管成像(OCTA)可以提供高分辨率三维成像,从而更直观地检测视网膜血管的变化,间接地反映脑神经元和血管的病理特征。就OCT测量视网膜厚度及OCTA测量视网膜血流变化在阿尔茨海默病诊断中的研究进展进行综述。 相似文献
9.
10.
Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed. 相似文献